Experiments with mouse models of breast cancer carrying frameshift mutations in the BRCA1 gene show that some tumours that initially were sensitive to anticancer therapy (specifically, cisplatin) may be capable of restoring the functionality of BRCA1(8). Here, BRCA1 is linked to breast carcinoma.